This map shows the geographic impact of A Frankel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Frankel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Frankel more than expected).
This network shows the impact of papers produced by A Frankel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Frankel. The network helps show where A Frankel may publish in the future.
Co-authorship network of co-authors of A Frankel
This figure shows the co-authorship network connecting the top 25 collaborators of A Frankel.
A scholar is included among the top collaborators of A Frankel based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with A Frankel. A Frankel is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Frankel, A, Kirill V. Rosen, Jorge Filmus, & Robert S. Kerbel. (2001). Induction of anoikis and suppression of human ovarian tumor growth in vivo by down-regulation of Bcl-X(L).. PubMed. 61(12). 4837–41.55 indexed citations
4.
Frankel, A, Si Ming Man, Peter J. Elliott, Julian Adams, & Robert S. Kerbel. (2000). Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341.. PubMed. 6(9). 3719–28.172 indexed citations
5.
Frankel, A, Robert Buckman, & Robert S. Kerbel. (1997). Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids.. PubMed. 57(12). 2388–93.152 indexed citations
6.
Frankel, A & Gordon B. Mills. (1996). Peptide and lipid growth factors decrease cis-diamminedichloroplatinum-induced cell death in human ovarian cancer cells.. PubMed. 2(8). 1307–13.67 indexed citations
7.
Shi, Yufang, A Frankel, Laszlo Radvanyi, et al.. (1995). Rapamycin enhances apoptosis and increases sensitivity to cisplatin in vitro.. PubMed. 55(9). 1982–8.194 indexed citations
8.
Xu, Yan, Douglas C. Gaudette, A Frankel, et al.. (1995). Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients.. PubMed. 1(10). 1223–32.285 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.